Prospective trial improved muscle strength and functional independence in paraplegic patients with spinal cord injury, suggesting vitamin D's key role in rehabilitation.
Objectives: This study aims to evaluate the effects of vitamin D supplementation at different doses and dose intervals on upper extremity muscle strength, muscle thickness, and functional independence of patients with paraplegic spinal cord injury (SCI). Patients and methods: This prospective controlled clinical trial included 64 paraplegic patients (45 males, 19 females; mean age: 39.7±11.5 years; range, 18 to 64 years) with serum 25-hydroxyvitamin D (25[OH]D) levels <20 ng/mL between June 2020 and June 2021. Participants were divided into three groups: control (n=20), daily supplementation with 6000 IU cholecalciferol (n=23), and weekly supplementation with 50,000 IU cholecalciferol (n=21) for eight weeks. Hand grip strength was assessed with a dynamometer, muscle thickness was measured using ultrasonography, and functional independence was evaluated with the Spinal Cord Independence Measure III. Results: Serum 25(OH)D levels significantly increased in both supplementation groups compared to baseline (p=0.001). Nondominant hand grip strength significantly improved in both groups (daily, p=0.025; weekly, p=0.038). Muscle thickness of the biceps brachii significantly increased in the daily group (p<0.05), while triceps brachii thickness significantly improved in both groups (p<0.001). Spinal Cord Independence Measure III scores, encompassing self-care, respiratory-sphincter control, and mobility, showed significant improvements in the supplementation groups (p<0.05), but no changes were observed in the control group. No significant differences were found between daily and weekly supplementation regimens. Conclusion: Vitamin D supplementation, whether daily or weekly, improved muscle performance and functional independence in individuals with SCI. While these findings support the inclusion of vitamin D replacement in rehabilitation programs, larger and longerterm studies are needed to confirm the benefits.
No takes yet. Share an insight, caveat, or question.
FERAHMAN et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: